PKS Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$648K Buy
706
+58
+9% +$58.8K 0.15% 139
2025
Q4
$697K Sell
648
-116
-15% -$111K 0.16% 128
2025
Q3
$583K Sell
764
-168
-18% -$125K 0.12% 142
2025
Q2
$726K Buy
932
+326
+54% +$253K 0.18% 111
2025
Q1
$498K Sell
606
-16
-3% -$13.3K 0.14% 134
2024
Q4
$481K Buy
+622
New +$515K 0.12% 146

Other funds holding LLY

PKS Advisory Services's LLY Position: Q1 2026 in Review

PKS Advisory Services increased its Eli Lilly (LLY) stake by 9% in Q1 2026, buying an estimated $58.8K and bringing the position to 706 shares worth $648K. The position accounts for 0.15% of the portfolio, ranked #139.

PKS Advisory Services first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $726K in Q2 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • PKS Advisory Services held 706 shares of Eli Lilly worth $648K as of Q1 2026.
  • PKS Advisory Services bought 58 Eli Lilly shares in Q1 2026, an estimated $58.8K.
  • Eli Lilly made up 0.15% of PKS Advisory Services's portfolio in Q1 2026, its #139 holding.
  • PKS Advisory Services first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • PKS Advisory Services's Eli Lilly position peaked at $726K in Q2 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on PKS Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.